{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:05:12Z","timestamp":1790406312623,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,22]]},"DOI":"10.7759\/cureus.97507","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T15:55:57Z","timestamp":1763826957000},"source":"Crossref","is-referenced-by-count":2,"title":["Cannabis-Induced Catatonia Complicated by Rhabdomyolysis, Acute Kidney Injury, and Sympathetic Overactivity: A Case Report"],"prefix":"10.7759","author":[{"given":"Sidharth","family":"Saira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Clinical manifestations, diagnosis, and empirical treatments for catatonia","volume":"4","author":"Bhati MT","year":"2007","unstructured":"Bhati MT, Datto CJ, O'Reardon JP. Clinical manifestations, diagnosis, and empirical treatments for catatonia. Psychiatry (Edgmont). 2007, 4:46-52.","journal-title":"Psychiatry (Edgmont)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2023-0113","article-title":"The diagnosis and treatment of catatonia","volume":"23","author":"Rogers JP","year":"2023","unstructured":"Rogers JP, Zandi MS, David AS. The diagnosis and treatment of catatonia. Clin Med (Lond). 2023, 23:242-5. 10.7861\/clinmed.2023-0113","journal-title":"Clin Med (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen SA","year":"2016","unstructured":"Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016, 6:391-8. 10.5498\/wjp.v6.i4.391","journal-title":"World J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.6613","article-title":"Catatonic symptoms appearing before autonomic symptoms help distinguish neuroleptic malignant syndrome from malignant catatonia","volume":"55","author":"Komatsu T","year":"2016","unstructured":"Komatsu T, Nomura T, Takami H, et al.. Catatonic symptoms appearing before autonomic symptoms help distinguish neuroleptic malignant syndrome from malignant catatonia. Intern Med. 2016, 55:2893-7. 10.2169\/internalmedicine.55.6613","journal-title":"Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1951965","article-title":"Malignant catatonia warrants early psychiatric-critical care collaborative management: two cases and literature review","volume":"2017","author":"Park J","year":"2017","unstructured":"Park J, Tan J, Krzeminski S, Hazeghazam M, Bandlamuri M, Carlson RW. Malignant catatonia warrants early psychiatric-critical care collaborative management: two cases and literature review. Case Rep Crit Care. 2017, 2017:1951965. 10.1155\/2017\/1951965","journal-title":"Case Rep Crit Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cells13131130","article-title":"Effects of cannabis on glutamatergic neurotransmission: the interplay between cannabinoids and glutamate","volume":"13","author":"Chowdhury KU","year":"2024","unstructured":"Chowdhury KU, Holden ME, Wiley MT, Suppiramaniam V, Reed MN. Effects of cannabis on glutamatergic neurotransmission: the interplay between cannabinoids and glutamate. Cells. 2024, 13:1130. 10.3390\/cells13131130","journal-title":"Cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17490","article-title":"Cannabis-induced malignant catatonia: a medical emergency and review of prior case series","volume":"13","author":"Sheikh B","year":"2021","unstructured":"Sheikh B, Hirachan T, Gandhi K, Desai S, Arif R, Isakov O. Cannabis-induced malignant catatonia: a medical emergency and review of prior case series. Cureus. 2021, 13:e17490. 10.7759\/cureus.17490","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8603","article-title":"Cannabis-induced catatonia: a case series","volume":"12","author":"Mekala H","year":"2020","unstructured":"Mekala H, Malik Z, Lone J, Shah K, Ishaq M. Cannabis-induced catatonia: a case series. Cureus. 2020, 12:e8603. 10.7759\/cureus.8603","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/life12122042","article-title":"GABAergic neurotransmission in human tissues is modulated by cannabidiol","volume":"12","author":"Ruffolo G","year":"2022","unstructured":"Ruffolo G, Gaeta A, Cannata B, et al.. GABAergic neurotransmission in human tissues is modulated by cannabidiol. Life (Basel). 2022, 12:2042. 10.3390\/life12122042","journal-title":"Life (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13040057","article-title":"Catatonia: clinical overview of the diagnosis, treatment, and clinical challenges","volume":"13","author":"Edinoff AN","year":"2021","unstructured":"Edinoff AN, Kaufman SE, Hollier JW, et al.. Catatonia: clinical overview of the diagnosis, treatment, and clinical challenges. Neurol Int. 2021, 13:570-86. 10.3390\/neurolint13040057","journal-title":"Neurol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","article-title":"","year":"2022","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing, Washington, D.C.; 2022. 10.1176\/appi.books.9780890425787https.\/\/doi.org\/10.1176\/appi.books.9780890425787."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","article-title":"Catatonia. II. Treatment with lorazepam and electroconvulsive therapy","volume":"93","author":"Bush G","year":"1996","unstructured":"Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996, 93:137-43. 10.1111\/j.1600-0447.1996.tb09815.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref13","article-title":"Electroconvulsive therapy in Lorazepam non-responsive catatonia","volume":"45","author":"Girish K","year":"2003","unstructured":"Girish K, Gill NS. Electroconvulsive therapy in Lorazepam non-responsive catatonia. Indian J Psychiatry. 2003, 45:21-5.","journal-title":"Indian J Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0b013e3182887a1a","article-title":"Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy","volume":"29","author":"Unal A","year":"2013","unstructured":"Unal A, Bulbul F, Alpak G, Virit O, Copoglu US, Savas HA. Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy. J ECT. 2013, 29:206-9. 10.1097\/YCT.0b013e3182887a1a","journal-title":"J ECT"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00378-2","article-title":"Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia","volume":"42","author":"Petrides G","year":"1997","unstructured":"Petrides G, Divadeenam KM, Bush G, Francis A. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry. 1997, 42:375-81. 10.1016\/S0006-3223(96)00378-2","journal-title":"Biol Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers JP","year":"2023","unstructured":"Rogers JP, Oldham MA, Fricchione G, et al.. Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023, 37:327-69. 10.1177\/02698811231158232","journal-title":"J Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.6.510","article-title":"Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases","volume":"187","author":"Arendt M","year":"2005","unstructured":"Arendt M, Rosenberg R, Foldager L, Perto G, Munk-J\u00f8rgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry. 2005, 187:510-5. 10.1192\/bjp.187.6.510","journal-title":"Br J Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424163-cannabis-induced-catatonia-complicated-by-rhabdomyolysis-acute-kidney-injury-and-sympathetic-overactivity-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T15:55:57Z","timestamp":1763826957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424163-cannabis-induced-catatonia-complicated-by-rhabdomyolysis-acute-kidney-injury-and-sympathetic-overactivity-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.97507","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,22]]}}}